Our study revealed decreased CCR5 surface expression on monocytes from SSc patients with ILD, but also showed that surface expression of CCR2 and CCR5 negatively correlated with analgesic/anti-inflammatory and immunosuppressant use. Here, CCR2 is linked to interstitial lung disease.